Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (R37AI054165, R01AI122991)
Received: 5 December 2018
Accepted: 30 April 2019
First Online: 22 May 2019
Ethics approval and consent to participate
: The FLUVACS study was approved by the Institutional Review Board of the University of Michigan Medical School. All participants provided written informed consent before enrollment.
: Not applicable.
: Arnold S. Monto declares grant support from Sanofi Pasteur and consultancy fees from Sanofi Pasteur, Novartis, and Novavax. Peter B. Gilbert declares grant support from Sanofi Pasteur.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.